NCNA NuCana plc ADRs

NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$0.78  -0.46 (-37.10%)
As of 03/27/2023 12:35:22 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  
IPO date:  09/28/2017
Outstanding shares:  52,180,000
Average volume:  104,721
Market cap:   $74,617,400
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%